ProCE Banner Series

Personalizing Myelofibrosis Care: Expert Insights on New Evidence and Novel Strategies

Join us for a 1-hour ACCME MOC/ACPE/ANCC/AAPA-certified workshop series focused on integrating the latest evidence on the management of myelofibrosis into personalized treatment plans to optimize the outcomes for patients with myelofibrosis.

  AAPA
  | ACPE
  | AMA
  | ANCC
Who Should Attend

This activity has been designed to meet the educational needs of hematologists/oncologists, pharmacists, physician associates, nurse practitioners, nurses, and other healthcare professionals involved in managing patients with myelofibrosis.

All Events

Personalizing Myelofibrosis Care: Expert Insights on New Evidence and Novel Strategies

Past Events

April

13

2024

1:30 PM - 2:30 PM Pacific Time (PT)

Virtual

CCO Simulcast | Host Group NV, Las Vegas, Nevada

Faculty

ProCE Banner Faculty
Raajit K. Rampal, MD, PhD

Associate Member
Director, MPN and Rare Hematologic Malignancies Program
Director, Center for Hematologic Malignancies
Memorial Sloan Kettering Cancer Center
New York, New York

ProCE Banner Faculty
Brady L. Stein, MD, MHS

Professor of Medicine
Department of Hematology/Oncology
Northwestern University Feinberg School of Medicine
Chicago, Illinois

ProCE Banner Faculty
Pankit Vachhani, MD

Associate Professor of Medicine, UAB Division of Hematology/Oncology
Medical Director, Clinical Research Unit (CRU) at UAB
O’Neal Comprehensive Cancer Center at UAB
Birmingham, Alabama

Topics

Myeloproliferative neoplasms

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.

CME/CE Info

Goal Statement
The goal of this program is to improve the knowledge, competence, and performance of learners in effort to optimize treatment for patients with Myelofibrosis.

Target Audience
This activity has been designed to meet the educational needs of hematologists/oncologists, pharmacists, physician associates, nurse practitioners, nurses, and other healthcare professionals involved in managing patients with myelofibrosis.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Describe factors that contribute to cancer health disparities and their potential impact on outcomes for patients with MF
  • Integrate available therapies into an optimal first-line treatment strategy for patients with MF, considering risk stratification, molecular features, cytogenetics, and symptom burden
  • Design evidence-based second-line treatment approaches for patients with MF who are relapsed, refractory, or intolerant to prior JAKi therapy
  • Evaluate the toxicity profiles of current and emerging therapies to develop AE management plans that support patients' QoL and treatment continuity
  • Summarize new data on emerging agents to facilitate discussions about ongoing trial opportunities with eligible patients

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1.0 contact hours (0.1 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number: JA4008176-0000-24-047-L01-P 

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Physician Associate Continuing Medical Education

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. PAs should only claim commensurate with the extent of their participation.

American Board of Internal Medicine Maintenance of Certification

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. 

For ABIM MOC points, your information will be shared with the ABIM through CCO's Joint Accreditation Program and Activity Reporting System (JAPARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records. 

By sharing your Diplomate Board ID # and DOB, you are giving Clinical Care Options, LLC permission to use this information/data to report your participation to these Boards via the Joint Accreditation Program and Activity Reporting System (JA-PARS). 

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC.

Supported by educational grants from AbbVie Inc. and Incyte Corporation.